Search

everythinglearnresearchcommunity

for

Search:↓

TR3 is mainly found in hair follicle stem cells and may be involved in hair loss.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Retinoids are effective for skin conditions like severe acne and psoriasis but must be used with caution due to potential side effects and risks during pregnancy.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

Loss of the Y chromosome and UTY gene activity increases cancer risk in men.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

Cirsium japonicum var. spinossimum seeds may help reduce inflammation and fight cancer.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.